A Stanford-trained engineer has pioneered a blood test that can detect colon cancer through DNA fragments. The FDA-approved technology represents a significant advancement in liquid biopsies and could transform routine cancer screening.
The Engineering Approach to Cancer Detection
According to reports from Business Insider, a Silicon Valley engineer has developed a blood test capable of detecting colon cancer through analyzing cancer DNA fragments in the bloodstream. Helmy Eltoukhy, co-CEO of Guardant and Stanford electrical engineering alumnus, reportedly approached cancer detection as an engineering challenge after witnessing the “diagnostic odyssey” patients endure.